STOCK TITAN

Full Alliance Group (OTC: FAGI) Accelerates Commercial Strategy for Aquaox Pure Solutions Featuring Nanobubble HOCl Technology

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags
Full Alliance Group (FAGI) has announced significant progress in commercializing its subsidiary Aquaox Pure Solutions' nanobubble-enhanced hypochlorous acid (HOCl) technology. The platform represents an innovative solution targeting the $60 billion global disinfectant and skincare markets. The company's proprietary technology uses stabilized nanobubbles to enhance HOCl's stability and efficacy, creating a clean-label, broad-spectrum antimicrobial solution. Aquaox is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors. The company's Tampa facility is expanding to support branded and white-label production, with applications ranging from personal hygiene to medical-grade disinfection. The technology offers industrial-strength performance with skin-safe application, positioning Aquaox as a platform for scalable innovation in multiple markets.
Full Alliance Group (FAGI) ha annunciato importanti progressi nella commercializzazione della tecnologia a base di acido ipocloroso (HOCl) potenziata da nanobolle della sua controllata Aquaox Pure Solutions. Questa piattaforma rappresenta una soluzione innovativa rivolta ai mercati globali dei disinfettanti e della cura della pelle, del valore di 60 miliardi di dollari. La tecnologia proprietaria dell'azienda utilizza nanobolle stabilizzate per migliorare la stabilità e l'efficacia dell'HOCl, creando una soluzione antimicrobica a etichetta pulita e ad ampio spettro. Aquaox sta cercando partnership strategiche di licenza nei settori sanitario, della cura personale, industriale e consumer. Lo stabilimento di Tampa dell'azienda si sta ampliando per supportare la produzione sia a marchio proprio che in white-label, con applicazioni che spaziano dall'igiene personale alla disinfezione di grado medico. La tecnologia offre prestazioni industriali con un'applicazione sicura per la pelle, posizionando Aquaox come una piattaforma per l'innovazione scalabile in diversi mercati.
Full Alliance Group (FAGI) ha anunciado avances significativos en la comercialización de la tecnología de ácido hipocloroso (HOCl) mejorada con nanoburbujas de su subsidiaria Aquaox Pure Solutions. Esta plataforma representa una solución innovadora dirigida a los mercados globales de desinfectantes y cuidado de la piel, valorados en 60 mil millones de dólares. La tecnología propietaria de la empresa utiliza nanoburbujas estabilizadas para mejorar la estabilidad y eficacia del HOCl, creando una solución antimicrobiana de etiqueta limpia y de amplio espectro. Aquaox está buscando asociaciones estratégicas de licencia en los sectores de salud, cuidado personal, industrial y de consumo. La planta de Tampa de la empresa se está ampliando para apoyar la producción de marca propia y de etiqueta blanca, con aplicaciones que van desde la higiene personal hasta la desinfección de grado médico. La tecnología ofrece un rendimiento industrial con aplicación segura para la piel, posicionando a Aquaox como una plataforma para la innovación escalable en múltiples mercados.
Full Alliance Group(FAGI)는 자회사 Aquaox Pure Solutions의 나노버블 강화 차아염소산(HOCl) 기술 상용화에서 중요한 진전을 발표했습니다. 이 플랫폼은 600억 달러 규모의 글로벌 소독제 및 스킨케어 시장을 겨냥한 혁신적인 솔루션입니다. 회사의 독자적인 기술은 안정화된 나노버블을 사용해 HOCl의 안정성과 효능을 향상시켜, 클린 라벨의 광범위 항균 솔루션을 만듭니다. Aquaox는 의료, 개인 관리, 산업 및 소비자 부문 전반에 걸쳐 전략적 라이선스 파트너십을 추진 중입니다. 회사의 탬파 시설은 브랜드 및 화이트 라벨 생산을 지원하기 위해 확장 중이며, 개인 위생부터 의료용 소독까지 다양한 용도를 갖추고 있습니다. 이 기술은 산업용 강도의 성능과 피부에 안전한 적용을 제공하여, Aquaox를 여러 시장에서 확장 가능한 혁신 플랫폼으로 자리매김하게 합니다.
Full Alliance Group (FAGI) a annoncé des progrès significatifs dans la commercialisation de la technologie à base d'acide hypochloreux (HOCl) améliorée par nanobulles de sa filiale Aquaox Pure Solutions. Cette plateforme représente une solution innovante ciblant les marchés mondiaux des désinfectants et des soins de la peau, évalués à 60 milliards de dollars. La technologie propriétaire de l'entreprise utilise des nanobulles stabilisées pour renforcer la stabilité et l'efficacité de l'HOCl, créant ainsi une solution antimicrobienne à large spectre et à étiquette propre. Aquaox recherche des partenariats stratégiques de licence dans les secteurs de la santé, des soins personnels, de l'industrie et de la consommation. L'usine de Tampa de l'entreprise est en expansion pour soutenir la production sous marque propre et en marque blanche, avec des applications allant de l'hygiène personnelle à la désinfection de qualité médicale. La technologie offre des performances industrielles avec une application sûre pour la peau, positionnant Aquaox comme une plateforme d'innovation évolutive sur plusieurs marchés.
Full Alliance Group (FAGI) hat bedeutende Fortschritte bei der Kommerzialisierung der nanoblasenverstärkten Hypochlorsäure (HOCl)-Technologie seiner Tochtergesellschaft Aquaox Pure Solutions bekannt gegeben. Die Plattform stellt eine innovative Lösung dar, die auf den 60 Milliarden Dollar schweren globalen Markt für Desinfektionsmittel und Hautpflege abzielt. Die firmeneigene Technologie nutzt stabilisierte Nanoblasen, um die Stabilität und Wirksamkeit von HOCl zu verbessern und so eine saubere, breit wirksame antimikrobielle Lösung zu schaffen. Aquaox strebt strategische Lizenzpartnerschaften in den Bereichen Gesundheitswesen, Körperpflege, Industrie und Konsumgüter an. Die Produktionsstätte des Unternehmens in Tampa wird erweitert, um sowohl Marken- als auch White-Label-Produktion zu unterstützen, mit Anwendungen von der persönlichen Hygiene bis hin zur medizinischen Desinfektion. Die Technologie bietet industrielle Leistungsfähigkeit bei hautverträglicher Anwendung und positioniert Aquaox als Plattform für skalierbare Innovationen in verschiedenen Märkten.
Positive
  • Technology targets a large $60 billion global market opportunity
  • Proprietary nanobubble technology enhances HOCl stability and efficacy
  • Multiple revenue streams through branded products and strategic licensing opportunities
  • Clean-label formula meets growing demand for non-toxic alternatives
  • Expanding production facility in Tampa for increased manufacturing capacity
Negative
  • Early stage of commercialization with unproven market acceptance
  • Potential competition from established disinfectant manufacturers
  • Success dependent on securing strategic partnerships and licensing agreements

TAMPA, FL / ACCESS Newswire / June 10, 2025 / Full Alliance Group, Inc. (OTC PINK:FAGI) today announced major strides in the commercial development of its recently formed subsidiary, Aquaox Pure Solutions, LLC. The company's breakthrough nanobubble-enhanced hypochlorous acid (HOCl) platform represents a next-generation solution for the $60 billion global disinfectant and skincare markets.

Aquaox's proprietary approach uses stabilized nanobubbles-microscopic gas-filled structures-to significantly improve the stability and efficacy of HOCl, a naturally occurring antimicrobial agent widely recognized for its safety and broad-spectrum performance. The result is a highly effective, clean-label formula well-suited for a range of fast-growing markets, including hospital-grade disinfection, dermatology, wound care, agriculture, and food safety.

"We believe Aquaox Pure Solutions offers one of the most scalable and investable HOCl technologies available today," said Michel Van Schaik, President of Aquaox Pure Solutions. "Our formulations are clean, potent, and uniquely shelf-stable-offering a meaningful advantage over conventional chlorine-based options."

Built for Scale and Strategic Licensing
Full Alliance Group is exploring strategic licensing and commercialization partnerships with companies across healthcare, personal care, industrial, and consumer sectors. Early-stage discussions with contract manufacturers and brand developers reflect growing interest in safe, sustainable antimicrobial solutions.

As part of its go-to-market strategy, Aquaox Pure Solutions is evaluating categories that include:

  • Personal hygiene and pet care

  • Oral and skincare health

  • Commercial sanitation and food processing

  • Medical-grade disinfection and wound care

  • Agricultural and environmental purification

Production and Global Readiness
The company's Tampa, Florida-based production facility is expanding to support both branded and white-label formats. With e-commerce-ready packaging and a strict commitment to clean-label ingredients-free from stabilizers, alcohols, or bleach-Aquaox is positioning itself to meet international regulatory standards and rising consumer demand for non-toxic alternatives.

A Platform Technology, Not Just a Product
With its nanobubble HOCl formulations, Aquaox delivers the rare combination of industrial-strength performance and skin-safe application-bridging critical gaps across multiple sectors.

"This isn't just a disinfectant-it's a platform for scalable innovation," said Bill Heneghan. "We see long-term potential to drive licensing revenue while contributing meaningfully to public health and environmental safety."

Media Contact:

Full Alliance Group Inc. Investor Relations

Gabe Rodriguez, Erelations Group
erelationsgroup@gmail.com
(623) 261-9046

Pure Aquaox Solutions, LLC
Brett Phillips
brett@pureaquaox.com
(800) 895-4415

About Full Alliance Group, Inc.

Full Alliance Group, Inc. (OTC:FAGI) is a holding company in the health and wellness sector. FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.

About Aquaox Pure Solutions, LLC

Aquaox Pure Solutions, LLC is a leading manufacturer of hypochlorous acid products enhanced with nanobubble technology. Committed to sustainability and efficacy, PureAquaox serves diverse markets with applications ranging from healthcare to consumer products.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including but not limited to statements regarding future financial performance, business strategy, and plans and objectives for future operations. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Full Alliance Group, Inc.



View the original press release on ACCESS Newswire

FAQ

What is Full Alliance Group's (FAGI) new technology for disinfectants?

FAGI's subsidiary Aquaox Pure Solutions has developed a nanobubble-enhanced hypochlorous acid (HOCl) technology that improves stability and efficacy for disinfection and skincare applications.

What markets is FAGI targeting with its Aquaox Pure Solutions technology?

The company is targeting multiple markets including hospital-grade disinfection, dermatology, wound care, agriculture, food safety, personal hygiene, and pet care.

How does FAGI plan to commercialize its Aquaox Pure Solutions technology?

FAGI is pursuing strategic licensing partnerships across healthcare, personal care, industrial, and consumer sectors, while expanding its Tampa facility for branded and white-label production.

What is the market size for FAGI's disinfectant technology?

The technology targets the global disinfectant and skincare markets, valued at $60 billion.

What advantages does FAGI's Aquaox technology offer over conventional disinfectants?

The technology offers a clean-label, non-toxic formula free from stabilizers, alcohols, or bleach, while providing industrial-strength performance with skin-safe application.
Full Alliance Group Inc

OTC:FAGI

FAGI Rankings

FAGI Latest News

FAGI Stock Data

1.11M
123.95M
0.01%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Palm Springs